John Ellerton
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Charles A. Schiffer (3 shared papers)James F. Holland (2 shared papers)Alice B. Kornblith (2 shared papers)Jimmie C. Holland (2 shared papers)Lewis R. Silverman (3 shared papers)Richard A. Larson (3 shared papers)Rosalie Odchimar-Reissig (2 shared papers)Bayard L. Powell (2 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Annals of Oncology (2 papers)Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesBelgiumSouth Korea
In The Last Decade
John Ellerton
29 papers receiving 3.2k citations
John Ellerton's Hit Papers
Peers
Comparison fields: 5 of 99
- Hematology 1.4k
- Oncology 1.4k
- Genetics 429
- Cancer Research 388
- Molecular Biology 1.2k
Countries citing papers authored by John Ellerton
This map shows the geographic impact of John Ellerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ellerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ellerton more than expected).
Fields of papers citing papers by John Ellerton
This network shows the impact of papers produced by John Ellerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ellerton. The network helps show where John Ellerton may publish in the future.
Co-authors
The 25 scholars most cited alongside John Ellerton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B Hit paper breakdown → | 2002 | 1326 |
| 2 | 1994 | 455 | |
| 3 | Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial Hit paper breakdown → | 2017 | 429 |
| 4 | 2002 | 324 | |
| 5 | 2005 | 128 | |
| 6 | 2010 | 91 | |
| 7 | 1995 | 84 | |
| 8 | Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. | 1980 | 80 |
| 9 | 1993 | 75 | |
| 10 | 2020 | 60 | |
| 11 | 2008 | 40 | |
| 12 | 1999 | 32 | |
| 13 | 1993 | 29 | |
| 14 | 2017 | 29 | |
| 15 | 2017 | 24 | |
| 16 | 1991 | 20 | |
| 17 | 2016 | 18 | |
| 18 | 2017 | 17 | |
| 19 | 1992 | 15 | |
| 20 | 1979 | 14 |
About John Ellerton
John Ellerton is a scholar working on Oncology, Surgery, Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 3.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Urinary and Genital Oncology Studies (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers), Acute Myeloid Leukemia Research (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (1.4k citations), Oncology (1.4k citations), Genetics (429 citations), Cancer Research (388 citations) and Molecular Biology (1.2k citations). John Ellerton has collaborated with scholars based in United States, Belgium and South Korea. Frequent co-authors include Charles A. Schiffer, James F. Holland, Alice B. Kornblith, Jimmie C. Holland, Lewis R. Silverman, Richard A. Larson, Rosalie Odchimar-Reissig, Bayard L. Powell, Carlos M. DeCastro and Erin P. Demakos. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, JNCI Journal of the National Cancer Institute and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.